## Abstract This study was undertaken to evaluate the use of perflubron (perfluorooctylbromide) as an oral contrast agent for magnetic resonance (MR) imaging of patients with Crohn disease. MR examinations were performed before and after perflubron administration in 12 patients with documented Croh
Perflubron as a gastrointestinal MR imaging contrast agent in the pediatric population
β Scribed by G. S. Bisset; K. H. Emery; M. P. Meza; N. K. Rollins; S. Don; J. S. Shorr
- Publisher
- Springer-Verlag
- Year
- 1996
- Tongue
- English
- Weight
- 748 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0301-0449
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Recent in vitro studies suggested there is an optimal range of concentration and viscosity for a liquid formulation of oral magnetic particles (WIN 39996) for magnetic resonance (MR) imaging of the gastrointestinal (GI) tract. To determine whether this formulation is also effective in v
## Abstract A paramagnetic Yb(lll) complex that is the prototype of a novel class of probes for MRI and MRS has been developed. The complex displays highly shifted ^1^H resonances that are characterized by short relaxation times and, as such, may prove to be a valuable alternative in applications t
The potential utility of H2(17)O as a contrast agent has been demonstrated in biological solutions and isolated tissues but its use has been impaired by the need to run heavily T2-weighted spin-echo images. By choosing an appropriate steady-state free precession experiment sensitive to T1/T2, we hav
## Abstract ## Purpose To evaluate the potential of a new lipophilic paramagnetic complex [Gd(BzβTTDA)]^2β^ [(4s)β4βbenzylβ3,6,10βtri(carboxymethyl)β3,6,10βtriazadodecandioic acid]^2β^ designed for use as a hepatobiliary MR contrast agent. ## Materials and Methods MR imaging studies for normal a